A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2
2005 ◽
Vol 23
(16_suppl)
◽
pp. 8031-8031
◽
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. 8001-8001
◽
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. 8013-8013
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 28
(18)
◽
pp. 3002-3007
◽
2005 ◽
Vol 23
(36)
◽
pp. 9275-9281
◽
Keyword(s):
2006 ◽
Vol 24
(18_suppl)
◽
pp. 8506-8506
◽
Keyword(s):
2004 ◽
Vol 22
(12)
◽
pp. 2469-2476
◽
Keyword(s):
Keyword(s):